Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Forest Labs' Oh-So-Healthy Balance Sheet
Investopedia
Tuesday, January 26, 2010 - 12:29pm
tags:
Forest Labs
Earnings Preview: Abbott Labs
Seeking Alpha
Tuesday, January 26, 2010 - 12:27pm
tags:
Abbott Laboratories, earnings
Amylin Shares Rise on Expectations FDA Will Approve New Byetta
Bloomberg
Tuesday, January 26, 2010 - 10:14am
tags:
FDA, Amylin, diabetes, Byetta
New Novartis CEO: Cafepharma Reader, Former Heinz Exec
WSJ Online
Tuesday, January 26, 2010 - 9:38am
tags:
Novartis, cafepharma, Joe Jimenez, Pharma CEOs
China Aoxing Completes Trial of Pain Drug
Seeking Alpha
Tuesday, January 26, 2010 - 9:36am
tags:
clinical trials, China Aoxing, Tilidine
GenVec's Hearing Loss Program Gets Welcome Boost from Novartis
Seeking Alpha
Tuesday, January 26, 2010 - 9:35am
tags:
Novartis, GenVec
J&J sales climb, but profit falls on big charge
Yahoo/AP
Tuesday, January 26, 2010 - 9:01am
tags:
JNJ, earnings
AIDS Group Bans Merck Sales Reps Over Pricing
Pharmalot
Tuesday, January 26, 2010 - 9:00am
tags:
Merck, HIV, AIDS, sales reps, drug pricing
AstraZeneca Pressured Medical Mgr Over Seroquel
Pharmalot
Tuesday, January 26, 2010 - 8:58am
tags:
AstraZeneca, Seroquel
Acorda: After FDA Approval, What's Next for Ampyra?
Seeking Alpha
Tuesday, January 26, 2010 - 8:54am
tags:
AMPYRA, Acorda Therapeutics
Novo Nordisk shares rally on diabetes-drug approval
Marketwatch
Tuesday, January 26, 2010 - 8:53am
tags:
Novo Nordisk, Victoza, diabetes, FDA
Sirtris Handles Pfizer's Sirtuin Work Less than Admirably
Seeking Alpha
Tuesday, January 26, 2010 - 8:49am
tags:
Sirtris, Pfizer, GSK, Sirtuin
Russia: Big Pharma Seeking Out New Markets
Seeking Alpha
Tuesday, January 26, 2010 - 8:47am
tags:
Russia, Big Pharma, Merck, Pfizer, Sanofi
Novartis Net Rises 54%, Names New CEO
TheStreet.com
Tuesday, January 26, 2010 - 8:46am
tags:
Joe Jimenez, Novartis, earnings
U.S. Drug Giants Outmuscle S&P 500
Forbes
Tuesday, January 26, 2010 - 7:29am
tags:
Pfizer, drug stocks
Amgen reports slightly higher profit
Marketwatch
Tuesday, January 26, 2010 - 7:28am
tags:
Amgen, earnings
Teva Pharmaceuticals is the latest defendant in an Abbott Laboratories patent suit
Forbes
Tuesday, January 26, 2010 - 7:19am
tags:
Abbott Laboratories, Teva Pharmaceuticals, lawsuits, Simcor, generics
Sanofi-Aventis Obtains U.S. Antitrust Clearance on Chattem
Bloomberg
Tuesday, January 26, 2010 - 7:18am
tags:
M&A, Chattem, Sanofi
Novartis’s Jimenez Beats Out Reinhardt to Replace CEO Vasella
Bloomberg
Tuesday, January 26, 2010 - 7:17am
tags:
Novartis, Pharma CEOs, Daniel Vasella, Joe Jimenez
Pay-for-Delay Is Under the Spotlight
Motley Fool
Tuesday, January 26, 2010 - 7:12am
tags:
pay-for-delay, Novartis, Pfizer, Merck, Teva Pharmaceuticals, GSK, Mylan, generics

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.